[Long term oral anticoagulation: indications and problems]

Helia Robert-Ebadi1, Françoise Boehlen

  • 1Unité d'angiologie, HUG, 1211 Genève 14. helia.robert-ebadi@hcuge.ch

Revue Medicale Suisse
|April 5, 2008
PubMed

Insights

Long-term oral anticoagulation is crucial for conditions like atrial fibrillation but carries bleeding risks. Patient involvement in managing anticoagulation therapy improves treatment effectiveness and safety.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Context:

  • Established indications for long-term oral anticoagulation include atrial fibrillation, valvular heart disease, and venous thromboembolic disease.
  • Bleeding represents the primary complication associated with oral anticoagulation therapy.
  • Practical management challenges, such as patient compliance, INR variability, and frequent monitoring, impact treatment efficacy.

Purpose:

  • To highlight the key indications and major complication of long-term oral anticoagulation.
  • To identify practical challenges in managing long-term oral anticoagulation therapy.
  • To emphasize the importance of patient involvement in optimizing anticoagulation management.

Summary:

  • Oral anticoagulation is indicated for atrial fibrillation, valvular heart disease, and venous thromboembolic disease.
  • Bleeding is the main risk, and management is complicated by compliance issues, INR variability, and monitoring needs.
  • Patient engagement in decision-making and treatment enhances the efficacy and safety of oral anticoagulation.

Impact:

  • Improved patient outcomes through better adherence and understanding of anticoagulation therapy.
  • Reduced risk of bleeding complications and thromboembolic events.
  • Enhanced safety and effectiveness of long-term oral anticoagulation management by incorporating patient-centered strategies.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...